{"id":"W157430056","doi":"10.1182/blood.v122.21.396.396","title":"Long-Term Outcomes Of Ruxolitinib Therapy In Patients With Myelofibrosis: 3-Year Update From COMFORT-I","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Clinical endpoint; Internal medicine; Placebo; Population; Phases of clinical research; Intention-to-treat analysis; Randomized controlled trial; Surgery; Clinical trial; Gastroenterology; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004518104,0.0004019739,0.00161215,0.0006281713,0.0002317328,0.001416592,0.0005953838,0.0007144123,0.0009090941],"category_scores_gemma":[0.005157614,0.0001630847,0.001369001,0.001316678,0.000284013,0.0008432013,0.0005805084,0.001194996,0.0002380012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008049925,"about_ca_system_score_gemma":0.0008226768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008933009,"about_ca_topic_score_gemma":0.002050703,"domain_scores_codex":[0.9989291,0.0003118352,0.0002734303,0.0001219466,0.0002743982,0.00008938249],"domain_scores_gemma":[0.9927223,0.002506973,0.002591659,0.0002681081,0.001368596,0.0005422747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.04102157,0.001015227,0.2115285,0.005987926,0.005810924,0.0005261528,0.0005934241,0.001631155,0.004094386,0.0005541778,0.02551202,0.7017246],"study_design_scores_gemma":[0.007350389,0.01843436,0.8349096,0.003826568,0.01068752,0.002210359,0.0005092835,0.001586702,0.002442059,0.0006226343,0.1172242,0.0001963276],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4884161,0.489064,0.001454104,0.00400691,0.0004778849,0.0002239829,0.00993022,0.00008703262,0.006339771],"genre_scores_gemma":[0.853825,0.1177492,0.002300627,0.005472108,0.002071214,0.0004199096,0.01724204,0.00003774169,0.0008820131],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004518104,"threshold_uncertainty_score":0.02389431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0127215264568082,"score_gpt":0.2430661804205404,"score_spread":0.2303446539637322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}